Drug Cardwk 7 - drug card PDF

Preview

Summary

drug card...

Description

Drug Card Template Trade & Generic name Drug class Purpose of the drug

Interactions

Docusate Sodium (Colace) laxatives Prevention of constipation, rect-used as enema to soften fecal impaction PO adults- 240 mg 1x daily (docusate calcium), PO (Adults and Children >12 yr): 50–400 mg in 1–4 divided doses. By mouth; (Children 6–12 yr): 40–150 mg in 1–4 divided doses. (Children 3–6 yr): 20–60 mg in 1–4 divided doses. (Children 1 mo): 0.04–0.3 mg/kg/dose every 2–4 hr to a maximum of 0.6 mg/kg within an 8 hr period if necessary. For muscle relaxation- adults 2-10mg 3-4 times daily PO (Geriatric Patients or Debilitated Patients): 2–2.5 mg 1–2 times daily initially. PO (Children >6 mo): 1–2.5 mg 3–4 times daily. IM IV (Adults): 5–10 mg; may repeat in 2–4 hr (larger doses may be required for tetanus). Use with opioids or other CNS depressants, including other benzodiazepines, non-benzodiazepine sedative/hypnotics, anxiolytics, general anesthetics, muscle relaxants, antipsychotics, and alcohol may cause profound sedation, respiratory depression, coma, and death; reserve concurrent use for when alternative treatment options are inadequate. May decrease efficacy of levodopa, sedative effects may be decreased theophylline, concurrent use ritonavir is not

Purpose of the drug Dosage

Interactions

Common Side Effects

Adverse Effects Unique information (antidotes, nursing considerations/teaching points, criteria that must be met to give or hold the medication, and contraindications):

recommended. dizziness, drowsiness, lethargy, depression, hangover, ataxia, slurred speech, headache, paradoxical excitation, blurred vision, hypotension (IV), physical dependence and tolerance. Respiratory depression Take as directed, do not take more than prescribed, do not share medication. Medication may cause drowsiness, clumsiness, or unsteadiness. Advise patient to avoid driving or other activities requiring alertness until response to medication is known. Seizures: Patients on anticonvulsant therapy should always carry identification describing disease process and medication regimen....